Sign In
Buy HRTX
$0.496
-0.0012 (-0.241%)
At Close: Jul 31, 2026
Heron Therapeutics (HRTX) Upgraded to Strong Buy: Here's What You Should Know
01:02pm, Thursday, 11'th Jul 2024
Heron Therapeutics (HRTX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
New Strong Buy Stocks for July 11th
08:11am, Thursday, 11'th Jul 2024
SKIL, INKT, MLCO, GTLB, and HRTX have been added to the Zacks Rank #1 (Strong Buy) List on July 11, 2024.
Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")
08:00am, Tuesday, 02'nd Jul 2024
-The U.S. Food and Drug Administration ("FDA") assigned a Prescription Drug User Fee Act ("PDUFA") goal date of September 23, 2024 SAN DIEGO , July 2, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Na
Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")
08:05am, Wednesday, 29'th May 2024
SAN DIEGO, May 29, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the Prior Approval Supplement ("PA
5 Small Drug Stocks to Buy From a Recovering Industry
10:02am, Friday, 24'th May 2024
Innovation is expected to continue to drive the growth of the Zacks Medical-Drugs industry. HRTX, BVS, AQST, ACRV and CRDL may prove to be good additions to one's portfolio.
What Makes Heron Therapeutics (HRTX) a Strong Momentum Stock: Buy Now?
01:01pm, Tuesday, 21'st May 2024
Does Heron Therapeutics (HRTX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Heron Therapeutics, Inc. (NASDAQ:HRTX) Expected to Post Q2 2024 Earnings of ($0.05) Per Share
01:38am, Monday, 20'th May 2024
Heron Therapeutics, Inc. (NASDAQ:HRTX – Free Report) – Analysts at Capital One Financial increased their Q2 2024 earnings estimates for shares of Heron Therapeutics in a note issued to inv
Heron Therapeutics, Inc. (HRTX) Q1 2024 Earnings Call Transcript
02:38pm, Tuesday, 07'th May 2024
Heron Therapeutics, Inc. (NASDAQ:HRTX ) Q1 2024 Earnings Conference Call May 7, 2024 8:30 AM ET Company Participants Craig Collard - Chief Executive Officer Ira Duarte - Executive Vice President and C
Heron Therapeutics (HRTX) Reports Q1 Earnings: What Key Metrics Have to Say
10:36am, Tuesday, 07'th May 2024
While the top- and bottom-line numbers for Heron Therapeutics (HRTX) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metric
Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates
10:05am, Tuesday, 07'th May 2024
Heron Therapeutics (HRTX) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.27 per share a year ago.
Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates
08:00am, Tuesday, 07'th May 2024
Net Product Sales of $34.7 million, which increased from $29.6 million for the same period in 2023. Net Loss Per Share $(0.02), which decreased from $(0.27) for the same period in 2023.
Will Heron Therapeutics (HRTX) Report Negative Earnings Next Week? What You Should Know
11:05am, Tuesday, 30'th Apr 2024
Heron Therapeutics (HRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
08:00am, Wednesday, 24'th Apr 2024
SAN DIEGO , April 24, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the company will host a conference call and live web
Heron Therapeutics: Zynrelef Potentially Eases Shareholder Pain
04:24pm, Tuesday, 16'th Apr 2024
Heron Therapeutics: Zynrelef Potentially Eases Shareholder Pain
Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City
04:05pm, Thursday, 11'th Apr 2024
SAN DIEGO , April 11, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that it will host an Investor Day on Wednesday, May 15, 2
